Shen, Y. ., X. . Chen, H. . Zhang, and . H. Hu. “Long-Term Cost-Effectiveness Analysis of onceweekly Semaglutide Versus Dulaglutide for the Treatment of Type 2 Diabetes After the Renewal of the National Drug Reimbursement List in China”. Health Decision, vol. 2, no. S1, July 2024, doi:10.54844/hd.2024.0003.